Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Diabetes

• Publication date

  2017-01-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2337/db16-0755PMID 28057699PMCID PMC6237271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats

  2018cited by this paper
• Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function

  2018cited by this paper
• The acute anorexic effect of liraglutide, a GLP-1 receptor agonist, does not require functional leptin receptor, serotonin, and hypothalamic POMC and CART activities in mice.

  2016influential reference
• 5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats

  2016cited by this paper
• 5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats

  2016influential reference
• GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.

  2016cited by this paper
• Nutrient-induced glucagon like peptide-1 release is modulated by serotonin.

  2016influential reference
• Pharmacological stimulation of serotonin 5-HT1B receptors enhances increases in plasma active glucagon-like peptide-1 levels induced by dipeptidyl peptidase-4 inhibition independently of feeding in mice.

  2015cited by this paper
• 5‐Hydroxytryptamine Medications for the Treatment of Obesity

  2015influential reference
• Liraglutide for Type 2 diabetes and obesity: a 2015 update

  2015cited by this paper
• The Stomach-Derived Hormone Ghrelin Increases Impulsive Behavior

  2015cited by this paper
• Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity.

  2014cited by this paper
• Influence of ghrelin on the central serotonergic signaling system in mice.

  2014cited by this paper
• Exenatide Treatment Exerts Anxiolytic- and Antidepressant-Like Effects and Reverses Neuropathy in a Mouse Model of Type-2 Diabetes

  2014cited by this paper
• DNA Hypermethylation of the Serotonin Receptor Type-2A Gene Is Associated with a Worse Response to a Weight Loss Intervention in Subjects with Metabolic Syndrome

  2014cited by this paper
• Glucagon-like peptide 1 and appetite.

  2013cited by this paper
• Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6

  2013cited by this paper
• Serotonin depletion counteracts sex differences in anxiety-related behaviour in rat

  2013influential reference
• Incretin hormones and the satiation signal

  2013influential reference
• Using the rat forced swim test to assess antidepressant-like activity in rodents

  2012influential reference
• The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors

  2012cited by this paper
• Decreased plasma ghrelin contributes to anorexia following novelty stress.

  2011cited by this paper
• Preproglucagon neurons project widely to autonomic control areas in the mouse brain.

  2011cited by this paper
• The contribution of serotonin 5-HT2C and melanocortin-4 receptors to the satiety signaling of glucagon-like peptide 1 and liraglutide, a glucagon-like peptide 1 receptor agonist, in mice.

  2011cited by this paper
• The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test.

  2011cited by this paper
• Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia.

  2010cited by this paper
• Multicenter, placebo-controlled trial of lorcaserin for weight management.

  2010cited by this paper
• Loss of cholecystokinin and glucagon-like peptide-1-induced satiation in mice lacking serotonin 2C receptors.

  2009cited by this paper
• Targeting the serotonin 2C receptor for the treatment of obesity and type 2 diabetes

  2009cited by this paper
• Glucose Sensing in L Cells: A Primary Cell Study

  2008cited by this paper
• Opposing Roles for 5-HT2A and 5-HT2C Receptors in the Nucleus Accumbens on Inhibitory Response Control in the 5-Choice Serial Reaction Time Task

  2008cited by this paper
• Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus.

  2008cited by this paper
• Pharmacological, but not genetic, disruptions in 5-HT(2C) receptor function attenuate LPS anorexia in mice.

  2007cited by this paper
• Cortical 5-HT2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice

  2006cited by this paper
• Increased hypothalamic 5-HT2A receptor gene expression and effects of pharmacologic 5-HT2A receptor inactivation in obese Ay mice.

  2006cited by this paper
• 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion

  2004cited by this paper
• Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.

  2002cited by this paper
• Serotonin mediates CA1 spine density but is not crucial for ovarian steroid regulation of synaptic plasticity in the adult rat dorsal hippocampus

  2002influential reference
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake

  2000cited by this paper
• Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system

  1999cited by this paper
• SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.

  1997cited by this paper
• Stimulation of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotropin releasing factor.

  1996cited by this paper
• A role for glucagon-like peptide-1 in the central regulation of feeding

  1996cited by this paper
• Serotonergic control of the organization of feeding and satiety.

  1995influential reference
• The effect of food deprivation on brain and gastrointestinal tissue levels of tryptophan, serotonin, 5‐hydroxyindoleacetic acid, and melatonin

  1992cited by this paper
• The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors.

  1990cited by this paper
• Structure and functional expression of cloned rat serotonin 5HT‐2 receptor.

  1988cited by this paper
• Origin of serotonin innervation of the arcuate and ventromedial hypothalamic region.

  1987cited by this paper
• The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat.

  1983cited by this paper
• Accumulation of hypothalamic endorphins after repeated injections of anorectics which release serotonin.

  1982cited by this paper
• Serotonergic influences on food intake: effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats.

  1979cited by this paper
• DIFFERENTIAL EFFECTS OF p‐CHLOROPHENYLALANINE AND 5,7‐DIHYDROXYTRYPTAMINE ON FEEDING IN RATS

  1978cited by this paper
• Depression: a new animal model sensitive to antidepressant treatments

  1977cited by this paper
• Hyperphagia and obesity following serotonin depletion by intraventricular p-chlorophenylalanine.

  1976cited by this paper
• Hyperphagia and increased growth in rats after intraventricular injection of 5,7-dihydroxytryptamine.

  1976cited by this paper
• Para-chlorophenylalanine, serotonin and killing behavior.

  1975cited by this paper

• Role of central and peripheral serotonin in liver physiology and diseases

  2026cites this paper
• Narrative review on glucagon-like peptide-1 receptor agonists and late-life depression: a new frontier in geriatric psychiatry?

  2025cites this paper
• Lithium Toxicity and Altered Clearance Following Initiation of Semaglutide in Patients With Bipolar Disorder: A Case Series and Literature Review.

  2025cites this paper
• GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective

  2025cites this paper
• Impact of GLP‐1 Receptor Agonists on Suicide Behavior: A Meta‐Analysis Based on Randomized Controlled Trials

  2025cites this paper
• GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity.

  2025cites this paper
• Psychiatric and psychological adverse effects associated with dulaglutide, semaglutide, and liraglutide: A vigibase study.

  2025cites this paper
• The Dorsal Raphe Nucleus and the Integrative Control of Feeding: A Report on Research Supported by Pathway to Stop Diabetes.

  2025cites this paper
• Leptin Activation of Dorsal Raphe Neurons Inhibits Feeding Behavior

  2024cites this paper
• GLP-1 and Its Analogs: Does Sex Matter?

  2024cites this paper
• Novel neural pathways targeted by GLP-1R agonists and bariatric surgery

  2024cites this paper
• Perspectives on obesity imaging: [18F]2FNQ1P a specific 5-HT6 brain PET radiotracer

  2024cites this paper
• The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius

  2024cites this paper
• Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.

  2024cites this paper
• Interaction of serotonin/GLP-1 circuitry in a dual preclinical model for psychiatric disorders and metabolic dysfunction.

  2024cites this paper
• Deciphering the therapeutic potential of SheXiangXinTongNing: Interplay between gut microbiota and brain metabolomics in a CUMS mice model, with a focus on tryptophan metabolism.

  2024cites this paper
• Liraglutide and Naringenin relieve depressive symptoms in mice by enhancing Neurogenesis and reducing inflammation.

  2024cites this paper
• Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats

  2024cites this paper
• Inhalation of diesel exhaust particulate matter accelerates weight gain via regulation of hypothalamic appetite-related genes and gut microbiota metabolism.

  2024cites this paper
• Tonic noradrenergic input to neurons in the dorsal raphe nucleus mediates food intake in male mice.

  2024cites this paper
• Discordance between assessments of food cue responsiveness: Implications for assessment in youth with overweight/obesity.

  2023cites this paper
• Microbiota: A potential orchestrator of antidiabetic therapy

  2023cites this paper
• Сучасні підходи до комплексного лікування ожиріння з пацієнторієнтованим підходом

  2023cites this paper
• Exploring the potential impact of GLP-1 receptor agonists in cancer therapy.

  2023cites this paper
• Serotonergic regulation of appetite and sodium appetite

  2023cites this paper
• Effectiveness of Motivational Counseling for Lifestyle Modification in Obese Patients Using a Patient-centered Approach

  2023cites this paper
• GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder

  2023cites this paper
• Cognition and serotonin in Parkinson's disease.

  2022cites this paper
• Mental Health and Sleep Disorders in Obese Patients, Their Relationship with Clinical and Pathogenetic Changes in the Organism and Impact on Quality of Life

  2022cites this paper
• Do psychedelics have therapeutic potential for obesity?

  2022cites this paper
• Roux-en-Y Gastric Bypass Can Modulate Methylation Level of Ghrelin Gene: a 6-Month Longitudinal Study

  2022cites this paper
• Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice

  2022cites this paper
• The serotonergic system dysfunction in diabetes mellitus

  2022cites this paper
• GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

  2022cites this paper
• The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases

  2022cites this paper
• Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity.

  2021cites this paper
• Central serotonin participates in the anorexigenic effect of GLP-1 in rainbow trout (Oncorhynchus mykiss).

  2021cites this paper
• Serotonin, food intake, and obesity

  2021cites this paper
• Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment.

  2021cites this paper
• Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation

  2021cites this paper
• The diverse effects of brain glucagon‐like peptide 1 receptors on ingestive behaviour

  2021cites this paper
• Changes in Plasma Ghrelin, Leptin, Insulin and Glucagon- Like Peptide-1 Levels Are Correlated to Body Mass Index among Patients with Early Asymptomatic Non-Alcoholic Fatty Liver

  2021cites this paper
• Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose

  2021cites this paper
• Duarte-Almeida 2020-0036-MS_CN

  2021cites this paper
• The dorsal raphe nucleus in the control of energy balance.

  2021cites this paper
• α-1 Adrenoceptor Activation in the Dorsal Raphe Nucleus Decreases Food Intake in Fasted Rats

  2021cites this paper
• Ion channels as therapeutic targets for type 1 diabetes mellitus.

  2020cites this paper
• Glucagon-like peptide-1 receptor agonist versus basal insulin in type-2 diabetic patients: An efficacy and safety analysis

  2020cites this paper
• Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota

  2020cites this paper
• Injections of the α-2 adrenoceptor agonist clonidine into the dorsal raphe nucleus increases food intake in satiated rats.

  2020cites this paper
• Antagonistic interaction between central glucagon-like Peptide-1 and oxytocin on diet-induced obesity mice

  2020cites this paper
• TPH2 in the dorsal Raphe nuclei regulates energy balance in a sex-dependent manner.

  2020cites this paper
• Multiple ancestral haplotypes harboring regulatory mutations cumulatively contribute to a QTL affecting chicken growth traits

  2020cites this paper
• Brain–gut–microbiome interactions in obesity and food addiction

  2020cites this paper
• Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis

  2020cites this paper
• The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naïve male mice.

  2020cites this paper
• The supramammillary nucleus controls anxiety-like behavior; key role of GLP-1R.

  2020cites this paper
• Multiple ancestral haplotypes harboring regulatory mutations cumulatively contribute to a QTL affecting chicken growth traits

  2020cites this paper
• Of mice and men: incretin actions in the central nervous system.

  2019cites this paper
• Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.

  2019cites this paper
• Stereotaxic Coordinates and Morphological Characterization of a Unique Nucleus (CSF-Contacting Nucleus) in Rat

  2019cites this paper
• Glucagon-Like Peptide-1 (GLP-1) and 5-Hydroxytryptamine 2c (5-HT2c) Receptor Agonists in the Ventral Tegmental Area (VTA) Inhibit Ghrelin-Stimulated Appetitive Reward

  2019cites this paper
• Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output

  2019cites this paper
• Role of neurotransmitters 5-hydroxytryptamine and substance P in anorexia induction following oral exposure to the trichothecene T-2 toxin.

  2019cites this paper
• Brain Feeding Circuits after Roux-en-Y Gastric Bypass.

  2018cites this paper
• Liraglutide, a GLP-1 Receptor Agonist, Which Decreases Hypothalamic 5-HT2A Receptor Expression, Reduces Appetite and Body Weight Independently of Serotonin Synthesis in Mice

  2018influential citation
• Brainstem GLP‐1 signalling contributes to cancer anorexia‐cachexia syndrome in the rat

  2018cites this paper
• Аналог глюкагоноподобного пептида-1 лираглутид (Саксенда®): механизм действия, эффективность в лечении ожирения

  2018cites this paper
• Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats

  2018cites this paper
• Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function

  2018cites this paper
• Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota

  2018cites this paper
• Glutamatergic Alterations in STZ-Induced Diabetic Rats Are Reversed by Exendin-4

  2018cites this paper
• Anti-Obesity Therapy: from Rainbow Pills to Polyagonists

  2018cites this paper
• Hyperhomocysteinemia influenced malnutrition in Parkinson’s disease patients

  2018cites this paper
• Anorectic responses to T-2 toxin, HT-2 toxin, diacetoxyscirpenol and neosolaniol correspond to plasma elevations of neurotransmitters 5-hydroxytryptamine and substance P.

  2018cites this paper
• Psychopharmacological advances in eating disorders

  2018cites this paper
• Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus

  2018cites this paper
• Does brainstem-derived serotonin mediate GLP-1 receptor agonist-induced suppression of appetite and body weight via 5-HT2A receptors?

  2017cites this paper
• Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

  2017cites this paper
• The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome

  2017cites this paper
• Roles of Gut Hormones in the Regulation of Food Intake and Body Weight

  2017cites this paper
• Neural circuits of eating behaviour: Opportunities for therapeutic development

  2017cites this paper
• Central Modulation of Energy Homeostasis and Cognitive Performance After Bariatric Surgery.

  2017cites this paper
• Obesity: 5-HT2A in GLP1-mediated weight loss

  2017cites this paper
• Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

  2017cites this paper
• The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction

  2017cites this paper
• Nutrient-induced glucagon like peptide-1 release is modulated by serotonin.

  2016cites this paper